These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3108397)

  • 1. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.
    Brindley PJ; Sher A
    J Immunol; 1987 Jul; 139(1):215-20. PubMed ID: 3108397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
    Brindley PJ; Strand M; Norden AP; Sher A
    Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
    Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
    Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen.
    Hall TM; Joseph GT; Strand M
    Exp Parasitol; 1995 Mar; 80(2):242-9. PubMed ID: 7534724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma: a 200-kDa chemotherapeutic target antigen is differentially localized in African vs Oriental species.
    Tanaka TM; Skubitz AP; Strand M
    Exp Parasitol; 1993 May; 76(3):293-301. PubMed ID: 7684706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.
    Doenhoff MJ; Modha J; Lambertucci JR
    Immunology; 1988 Dec; 65(4):507-10. PubMed ID: 3146547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cellular and humoral immunity and helper cell involvement in permissiveness to infection by Schistosoma mansoni.
    Mendlovic F; Tarrab-Hazdai R; Arnon R
    Eur J Immunol; 1987 Aug; 17(8):1151-7. PubMed ID: 2957216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
    Botros SS; Hammam O; Mahmoud M; Bergquist R
    APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.
    Modha J; Lambertucci JR; Doenhoff MJ; McLaren DJ
    Parasite Immunol; 1990 May; 12(3):321-34. PubMed ID: 2117266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel binds Schistosoma mansoni adult worm actin.
    Tallima H; El Ridi R
    Int J Antimicrob Agents; 2007 May; 29(5):570-5. PubMed ID: 17341443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM; Grzych JM; Pierce RJ; Capron A
    J Immunol; 1987 May; 138(10):3448-53. PubMed ID: 3106483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni and S. japonicum: decline of antibodies against diagnostic adult worm antigens (Sm31/32) following praziquantel treatment of mice.
    Ruppel A; Xing Y; Dell R; Numrich P; Shi YE
    Trop Med Parasitol; 1991 Dec; 42(4):325-31. PubMed ID: 1796226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms.
    Jankovic D; Wynn TA; Kullberg MC; Hieny S; Caspar P; James S; Cheever AW; Sher A
    J Immunol; 1999 Jan; 162(1):345-51. PubMed ID: 9886405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination.
    William S; Botros S
    Int J Parasitol; 2004 Jul; 34(8):971-7. PubMed ID: 15217736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.
    Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA
    J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies.
    Damonneville M; Auriault C; Verwaerde C; Delanoye A; Pierce R; Capron A
    Clin Exp Immunol; 1986 Aug; 65(2):244-52. PubMed ID: 3098476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.